PLSCR4: Key Regulator of Immune Response and Disease (G57088)

Target Name: PLSCR4

NCBI ID: G57088

PLSCR4

PLSCR4: Key Regulator of Immune Response and Disease

PLSCR4 (Peripheral Landing Site for Cooperative Recognition) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. It is a key regulator of the immune response and has been implicated in a number of diseases, including autoimmune disorders, neurodegenerative diseases, and cancer.

One of the unique features of PLSCR4 is its ability to form complex interactions with other proteins, known as co-receptors. These interactions can lead to the formation of protein-protein bonds, which are important for the regulation of various cellular processes, including cell signaling, protein folding, and inflammation.

PLSCR4 has also been shown to play a key role in the regulation of T cell responses. T cells are a crucial part of the immune system and play a central role in the regulation of inflammation and tissue repair. PLSCR4 has been shown to regulate the activity of T cells, allowing them to respond to threats in a controlled and timely manner.

In addition to its role in T cell regulation, PLSCR4 has also been shown to play a key role in the regulation of inflammation. It has been shown to regulate the activity of immune cells, including neutrophils, and to play a role in the regulation of inflammatory cytokine production.

PLSCR4 has also been shown to play a role in the regulation of cellular signaling pathways. It has been shown to interact with a variety of signaling proteins, including TGF-β1, IL-6, and NF-kappa-B. These interactions can lead to the regulation of cellular processes, including cell growth, apoptosis, and inflammation.

In addition to its role in cellular signaling, PLSCR4 has also been shown to play a key role in the regulation of gene expression. It has been shown to interact with a variety of transcription factors, including SV40, NF-kappa-B, and AP-1. These interactions can lead to the regulation of gene expression, allowing PLSCR4 to play a role in the regulation of cellular processes that are important for overall health and wellbeing.

PLSCR4 has also been shown to play a role in the regulation of cellular processes that are important for the development and maintenance of tissues. It has been shown to play a key role in the regulation of cell migration, cell adhesion, and cell proliferation. These processes are important for the development and maintenance of tissues and are critical for the growth, repair, and function of organs and tissues.

In conclusion, PLSCR4 is a protein that has been shown to play a key role in a variety of cellular processes that are important for overall health and wellbeing. Its ability to form complex interactions with other proteins, as well as its role in the regulation of T cell responses, inflammation, cellular signaling pathways, gene expression, and cellular processes that are important for tissue development and maintenance make PLSCR4 an attractive potential drug target or biomarker. Further research is needed to fully understand the role of PLSCR4 in these processes and to develop effective treatments for the prevention and treatment of PLSCR4-related diseases.

Protein Name: Phospholipid Scramblase 4

Functions: May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. May play a central role in the initiation of fibrin clot formation, in the activation of mast cells and in the recognition of apoptotic and injured cells by the reticuloendothelial system

The "PLSCR4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLSCR4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets